Co-localization of prothrombin fragment F1+2 and VEGF-R2-bound VEGF in human colon cancer

Anticancer Research

Volumn 31, Issue 3, 2011, Pages 843-847

  Sierko, Ewa ^a,b   Wojtukiewicz, Marek Z ^a,b   Zimnoch, Lech ^a   Thorpe, Philip E ^c   Brekken, Rolf A ^d   Kisiel, Walter ^e  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Comprehensive Cancer Center in Bialystok   (Poland)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d HOPE HEART INSTITUTE   (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Coagulation factor; Colon cancer; Thrombin; Vascular endothelial growth factor; Vascular endothelial growth factor receptor 2

Indexed keywords

PROTHROMBIN; PROTHROMBIN ANTIBODY; PROTHROMBIN FRAGMENT F1+2; THROMBIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; COLON CANCER; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; STAINING;

ADULT; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN TRANSPORT; PROTHROMBIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 79956087357     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Iversen LH, Okholm M and Thorlacius-Ussing OO: Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease - a preliminary study. Thromb Haemost 76: 523-528, 1996. (Pubitemid 26372005)
2. Iversen LH and Thorlacius-Ussing OO: Relationship of coagulation test abnormalities to tumor burden and postoperative DVT in resected colorectal cancer. Thromb Haemost 87: 402-408, 2002.
3. Casillas S and Nicholson JD: Aortic thrombosis after low anterior resection for rectal cancer: report of a case. Dis Colon Rectum 45: 829-832, 2002. (Pubitemid 34602499)
4. Zacharski LR, Memoli VA, Morain WD, Schlaeppi JM and Rousseau SM: Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding. Thromb Haemost 73: 793-797, 1995.
5. Zacharski LR, Wojtukiewicz MZ, Costantini V, Ornstein DL and Memoli VA: Pathways of coagulation/fibrinolysis activation in malignancy. Semin Thromb Hemost 18: 104-116, 1992.
6. Wojtukiewicz MZ, Sierko E and Rak J: Contribution of hemostatic system to angiogenesis in cancer. Semin Thromb Hemost 30: 5-20, 2004. (Pubitemid 38457297)
7. Wojtukiewicz MZ, Tang DG, Ben-Josef E, Renaud C, Waltz DA and Honn KV: Solid tumor cells express functional tethered ligand thrombin receptor. Cancer Res 55: 698-704, 1995.
8. Wojtukiewicz MZ, Rucińska M, Zimnoch L, Jaromin J, Piotrowski Z, Różańska-Kudelska M, Kisiel W and Kudryk BJ: Expression of prothrombin fragment 1+2 in cancer tissue as an indicator of local activation of blood coagulation. Thromb Res 97: 335-342, 2000. (Pubitemid 30089038)
9. Wojtukiewicz MZ, Tang TG, Ciarelli JJ, Nelson KK, Walz DA, Diglio CA, Mammen EF and Honn KV: Thrombin increases the metastatic potential of tumor cell. Int J Cancer 54: 793-806, 1993.
10. Wojtukiewicz MZ, Tang TG, Nelson KK, Walz DA, Diglio CA and Honn KV: Thrombin enhances tumor cell adhesive and metastatic properties via increased αIIbβ3 expression on the cell surface. Thromb Res 68: 233-245, 1992.
11. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31, 1995.
12. Ferrara N: Vascular endothelial growth factor: basic science and clinical progress. Endocrine Rev 25: 581-611, 2004.
13. Hurwitz HI, Fehrenbacher L, Novotny WF, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R and Kabbinavar F: Bevacizumab plus irinotekan, fluorouracil, and leukovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342, 2004. (Pubitemid 38702844)
14. Kowanetz M and Ferrara N: Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 12: 5018-5022, 2006. (Pubitemid 44453326)
15. Wojtukiewicz MZ, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SM and Stump DC: Indirect activation of blood coagulation in colon cancer. Thromb Haemost 62: 1062-1066, 1989. (Pubitemid 20011490)
16. Tsopanoglou NE, Pipili-Synetos E and Maragoudakis ME: Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am J Physiol 264: C1302-C1307, 1993. (Pubitemid 23158838)
17. Maragoudakis ME, Tsopanoglou NE, Sakkoula E and Pipili-Synetos E: On the mechanism of promotion of angiogenesis by thrombin. FASEB J 9: A587J, 1995.
18. Zania P, Papaconstantinou M, Flordellis CS, Maragoudakis ME and Tsopanoglou NE: Thrombin mediates mitogenesis and survival of human endothelial cells through distinct mechanisms. Am J Physiol Cell Physiol 294: C1215-C1226, 2008.
19. Zubrod CG, Schneiderman M and Frei E III: Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 11: 7-33, 1960.
20. Brekken RA, Huang X, King SW and Thorpe PE: Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res 58: 1952-1959, 1998.
21. Brekken RA and Thorpe PE: VEGF-VEGF receptor complexes as markers of tumor vascular endothelium. J Control Rel 74: 173-181, 2001. (Pubitemid 32727619)
22. Sierko E, Wojtukiewicz MZ, Zawadzki R, Zimnoch L and Kisiel W: Expression of protein C (PC), protein S (PS) and thrombomodulin (TM) in human colorectal cancer. Thromb Res 125: 71-75, 2010.
23. Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjänen S, Syrjänen K, Collan Y and Pyrhönen S: VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival. Anticancer Res 28: 3865-3870, 2008.
24. Yonezawa M, Wada K, Tatsuguchi A, Akamatsu T, Gudis K, Seo T, Mitsui K, Nagata K, Tanaka S, Fujimori S and Sakamoto C: Heregulin-induced VEGF expression via the ErbB3 signaling pathway in colon cancer. Digestion 80: 215-225, 2009.
25. Cascio S, Ferla R, D'Andrea A, Gerbino A, Bazan V, Surmacz E and Russo A: Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. J Cell Physiol 221: 189-194, 2009.
26. Okita NT, Yamada Y, Takahari D, Hirashima Y, Matsubara J, Kato K, Hamaguchi T, Shirao K, Shimada Y, Taniguchi H and Shimoda T: Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer. Jpn J Clin Oncol 39: 595-600, 2009.
27. Caunt M, Hu L, Tang T, Brooks PC, Ibrahim S and Karpatkin S: Growth-regulated oncogene is pivotal in thrombin - induced angiogenesis. Cancer Res 66: 4125-4132, 2006.
28. Darmoul D, Gratio V, Devaud H, Lehy T and Laburthe M: Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 cell induces cell proliferation and motility in human colon cancer cells. Am J Pathol 162: 1503-1513, 2003.
29. Klepfish B, Greco MA and Karpatkin S: Thrombin stimulates melanoma tumor cell binding to endothelial cells and subendothelial matrix. Int J Cancer 53: 978-982, 1993. (Pubitemid 23119547)
30. Sarker KP, Biswas KK, Yamaji K, Yamakuchi M, Hashiguchi M, Lee KY and Maruyama I: Inhibition of thrombin-induced vascular endothelial growth factor production in human neuroblstoma (NB-1) cells by argatroban. Pathophysiol Haemost Thromb 34: 41-47, 2005. (Pubitemid 41642804)
31. Xu Y, Gu Y, Keep RF, Heth J, Muraszko KM, Xi G and Hua Y: Thrombin up-regulates vascular endothelial growth factor in experimental gliomas. Neurol Res 31: 759-765, 2009.
32. Sierko E and Wojtukiewicz MZ: Platelets and angiogenesis in malignancy. Semin Thromb Hemost 30: 95-108, 2004.
33. Rhim TH, Park ChS, Kim E and Kim SS: Human prothrombin fragment 1+2 inhibit bFGF-induced BCE cell growth. Biochem Biophys Res Commun 252: 513-516, 1998. (Pubitemid 28542919)